← Back to Search

Thiazolidinedione

Pioglitazone 15mg Dose for Breast Cancer

Phase 2
Recruiting
Led By Kristin H Lupinacci, DO
Research Sponsored by West Virginia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 weeks
Awards & highlights

Study Summary

This trial is testing if pioglitazone can help treat muscle fatigue in breast cancer patients.

Eligible Conditions
  • Breast Cancer
  • Muscle Fatigue

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Muscle Gene Expression
Secondary outcome measures
Body Weight
Muscle Fatigue

Trial Design

3Treatment groups
Active Control
Group I: Pioglitazone 15mg DoseActive Control1 Intervention
Subjects will be given PIO 15mg once daily, based on the randomization lists prepared by the WVUCI Biostatistics Core. This is a 1:1:1 randomization (10 in each group) without any planned stratification.
Group II: Pioglitazone 30mg DoseActive Control1 Intervention
Subjects will be given PIO 30mg once daily, based on the randomization lists prepared by the WVUCI Biostatistics Core. This is a 1:1:1 randomization (10 in each group) without any planned stratification.
Group III: No DrugActive Control1 Intervention
Subjects will be assigned to a no drug control group based on the randomization lists prepared by the WVUCI Biostatistics Core. This is a 1:1:1 randomization (10 in each group) without any planned stratification.

Find a Location

Who is running the clinical trial?

West Virginia UniversityLead Sponsor
177 Previous Clinical Trials
62,161 Total Patients Enrolled
3 Trials studying Breast Cancer
39 Patients Enrolled for Breast Cancer
Kristin H Lupinacci, DOPrincipal InvestigatorWest Virginia University
~9 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top